

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.94417714 |
| 2 | exogenous drug catabolic process (GO:0042738) | 8.31662019 |
| 3 | drug catabolic process (GO:0042737) | 8.08481017 |
| 4 | omega-hydroxylase P450 pathway (GO:0097267) | 7.72457093 |
| 5 | * ethanol oxidation (GO:0006069) | 7.63178830 |
| 6 | complement activation, alternative pathway (GO:0006957) | 7.45856239 |
| 7 | cellular glucuronidation (GO:0052695) | 6.83320577 |
| 8 | regulation of protein activation cascade (GO:2000257) | 6.67764647 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 6.56744458 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.56744458 |
| 11 | uronic acid metabolic process (GO:0006063) | 6.53177302 |
| 12 | glucuronate metabolic process (GO:0019585) | 6.53177302 |
| 13 | urea metabolic process (GO:0019627) | 6.49536896 |
| 14 | glyoxylate metabolic process (GO:0046487) | 6.43955125 |
| 15 | drug metabolic process (GO:0017144) | 6.43666632 |
| 16 | regulation of complement activation (GO:0030449) | 6.39819993 |
| 17 | * ethanol metabolic process (GO:0006067) | 6.34192859 |
| 18 | L-phenylalanine metabolic process (GO:0006558) | 6.25981318 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.25981318 |
| 20 | regulation of fibrinolysis (GO:0051917) | 6.23482524 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 5.93780988 |
| 22 | urea cycle (GO:0000050) | 5.76494911 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.73192981 |
| 24 | phenylpropanoid metabolic process (GO:0009698) | 5.37177436 |
| 25 | bile acid and bile salt transport (GO:0015721) | 5.34166845 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.28112658 |
| 27 | protein carboxylation (GO:0018214) | 5.28112658 |
| 28 | bile acid metabolic process (GO:0008206) | 5.10868326 |
| 29 | bile acid biosynthetic process (GO:0006699) | 5.07884624 |
| 30 | fibrinolysis (GO:0042730) | 5.06391627 |
| 31 | oxidative demethylation (GO:0070989) | 5.02420520 |
| 32 | complement activation, classical pathway (GO:0006958) | 4.90281726 |
| 33 | complement activation (GO:0006956) | 4.89619578 |
| 34 | protein activation cascade (GO:0072376) | 4.87482544 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.84778041 |
| 36 | flavonoid metabolic process (GO:0009812) | 4.80752939 |
| 37 | primary alcohol catabolic process (GO:0034310) | 4.65365759 |
| 38 | blood coagulation, intrinsic pathway (GO:0007597) | 4.63711809 |
| 39 | aromatic amino acid family catabolic process (GO:0009074) | 4.61023214 |
| 40 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.59565887 |
| 41 | negative regulation of sterol transport (GO:0032372) | 4.45097707 |
| 42 | negative regulation of cholesterol transport (GO:0032375) | 4.45097707 |
| 43 | imidazole-containing compound metabolic process (GO:0052803) | 4.41850172 |
| 44 | alkaloid metabolic process (GO:0009820) | 4.26174677 |
| 45 | serine family amino acid catabolic process (GO:0009071) | 4.24696544 |
| 46 | hormone catabolic process (GO:0042447) | 4.20009019 |
| 47 | negative regulation of blood coagulation (GO:0030195) | 4.16836232 |
| 48 | negative regulation of hemostasis (GO:1900047) | 4.16836232 |
| 49 | acute-phase response (GO:0006953) | 4.14828726 |
| 50 | regulation of humoral immune response (GO:0002920) | 4.11172407 |
| 51 | arginine metabolic process (GO:0006525) | 4.06912091 |
| 52 | negative regulation of protein activation cascade (GO:2000258) | 4.02454851 |
| 53 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.96202874 |
| 54 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.96202874 |
| 55 | glutamate metabolic process (GO:0006536) | 3.93986854 |
| 56 | regulation of plasminogen activation (GO:0010755) | 3.91227786 |
| 57 | negative regulation of coagulation (GO:0050819) | 3.86869427 |
| 58 | opsonization (GO:0008228) | 3.82190182 |
| 59 | S-adenosylmethionine metabolic process (GO:0046500) | 3.78943300 |
| 60 | tyrosine metabolic process (GO:0006570) | 3.78466638 |
| 61 | negative regulation of wound healing (GO:0061045) | 3.77696632 |
| 62 | protein-lipid complex remodeling (GO:0034368) | 3.77286893 |
| 63 | macromolecular complex remodeling (GO:0034367) | 3.77286893 |
| 64 | plasma lipoprotein particle remodeling (GO:0034369) | 3.77286893 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 3.76372755 |
| 66 | positive regulation of lipid catabolic process (GO:0050996) | 3.73720403 |
| 67 | intestinal absorption (GO:0050892) | 3.70770480 |
| 68 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.70151882 |
| 69 | acylglycerol homeostasis (GO:0055090) | 3.68070689 |
| 70 | triglyceride homeostasis (GO:0070328) | 3.68070689 |
| 71 | amino-acid betaine metabolic process (GO:0006577) | 3.67476879 |
| 72 | * xenobiotic metabolic process (GO:0006805) | 3.65191801 |
| 73 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.63012135 |
| 74 | phospholipid efflux (GO:0033700) | 3.62917335 |
| 75 | * primary alcohol metabolic process (GO:0034308) | 3.61267395 |
| 76 | doxorubicin metabolic process (GO:0044598) | 3.57107982 |
| 77 | daunorubicin metabolic process (GO:0044597) | 3.57107982 |
| 78 | polyketide metabolic process (GO:0030638) | 3.57107982 |
| 79 | high-density lipoprotein particle remodeling (GO:0034375) | 3.54819913 |
| 80 | cytolysis (GO:0019835) | 3.51534532 |
| 81 | regulation of cholesterol esterification (GO:0010872) | 3.46975565 |
| 82 | glycine metabolic process (GO:0006544) | 3.46357072 |
| 83 | negative regulation of complement activation (GO:0045916) | 3.45280575 |
| 84 | cholesterol efflux (GO:0033344) | 3.42692587 |
| 85 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.42593679 |
| 86 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.42593679 |
| 87 | alpha-amino acid catabolic process (GO:1901606) | 3.31791282 |
| 88 | sulfur amino acid catabolic process (GO:0000098) | 3.30498491 |
| 89 | ketone body metabolic process (GO:1902224) | 3.28450459 |
| 90 | drug transmembrane transport (GO:0006855) | 3.27905701 |
| 91 | regulation of bile acid biosynthetic process (GO:0070857) | 3.25498348 |
| 92 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.21366794 |
| 93 | negative regulation of humoral immune response (GO:0002921) | 3.19864411 |
| 94 | renal system process involved in regulation of blood volume (GO:0001977) | 3.18431914 |
| 95 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.18030871 |
| 96 | arginine catabolic process (GO:0006527) | 3.17737934 |
| 97 | negative regulation of lipase activity (GO:0060192) | 3.17297134 |
| 98 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.16898359 |
| 99 | positive regulation of hemostasis (GO:1900048) | 3.16792796 |
| 100 | positive regulation of blood coagulation (GO:0030194) | 3.16792796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.50485696 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.51232947 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.21369644 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.70120125 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.58019792 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.33552802 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.54420737 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.91987737 |
| 9 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.87739222 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.78993231 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.70116433 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.04054499 |
| 13 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.03880750 |
| 14 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.96217613 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.87410964 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.83907651 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.81626792 |
| 18 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.77929838 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.75801305 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.71313141 |
| 21 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.63619584 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.63214347 |
| 23 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.63143206 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61377573 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.60894990 |
| 26 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.58767460 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54738986 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.53828956 |
| 29 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.51330697 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48896734 |
| 31 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.47546173 |
| 32 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33430066 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.33128584 |
| 34 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.32601725 |
| 35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30945225 |
| 36 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.30844744 |
| 37 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.29145087 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28034572 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23506221 |
| 40 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21972869 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18981863 |
| 42 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.15357578 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14949571 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11612346 |
| 45 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.09493554 |
| 46 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.03383541 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03133415 |
| 48 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02064372 |
| 49 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01741054 |
| 50 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.00845265 |
| 51 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.00685984 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.93938432 |
| 53 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.91383599 |
| 54 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91151524 |
| 55 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.90759977 |
| 56 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.90016148 |
| 57 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.89818086 |
| 58 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.89789621 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87446856 |
| 60 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86723462 |
| 61 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86121827 |
| 62 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.85292623 |
| 63 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.81995493 |
| 64 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81318107 |
| 65 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81120476 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.80713489 |
| 67 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79149386 |
| 68 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.78663216 |
| 69 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77814546 |
| 70 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.77303867 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.77023148 |
| 72 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.76677217 |
| 73 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.76637174 |
| 74 | SA1_27219007_Chip-Seq_Bcells_Human | 0.75871937 |
| 75 | AR_20517297_ChIP-Seq_VCAP_Human | 0.74926574 |
| 76 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74598517 |
| 77 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.74479762 |
| 78 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.73984210 |
| 79 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.73693553 |
| 80 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.73640921 |
| 81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73615111 |
| 82 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.72898984 |
| 83 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.72625829 |
| 84 | CBP_21632823_ChIP-Seq_H3396_Human | 0.71821226 |
| 85 | NFYA_21822215_ChIP-Seq_K562_Human | 0.69224381 |
| 86 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.68796348 |
| 87 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.68423754 |
| 88 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68067245 |
| 89 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.67686482 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.66927624 |
| 91 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.66819786 |
| 92 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.66631265 |
| 93 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.66122989 |
| 94 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.64953829 |
| 95 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.63594943 |
| 96 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.63531705 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.63512205 |
| 98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.62961676 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.62930899 |
| 100 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.62500804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.12695193 |
| 2 | MP0005360_urolithiasis | 6.38786073 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.04504388 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 5.60688688 |
| 5 | MP0005365_abnormal_bile_salt | 5.42501329 |
| 6 | MP0001666_abnormal_nutrient_absorption | 3.66215134 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.66030356 |
| 8 | MP0003252_abnormal_bile_duct | 3.45917828 |
| 9 | MP0003195_calcinosis | 3.45443627 |
| 10 | MP0003868_abnormal_feces_composition | 3.06922648 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.56304472 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.31923493 |
| 13 | MP0005332_abnormal_amino_acid | 2.27494392 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.11179845 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.06485572 |
| 16 | MP0002876_abnormal_thyroid_physiology | 1.99076718 |
| 17 | MP0009840_abnormal_foam_cell | 1.87662194 |
| 18 | MP0004043_abnormal_pH_regulation | 1.73879907 |
| 19 | MP0000609_abnormal_liver_physiology | 1.70948405 |
| 20 | MP0009697_abnormal_copulation | 1.69590747 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.63316579 |
| 22 | MP0002132_abnormal_respiratory_system | 1.58429063 |
| 23 | MP0005670_abnormal_white_adipose | 1.58263899 |
| 24 | MP0001764_abnormal_homeostasis | 1.55055345 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.54395618 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.39742015 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.31043035 |
| 28 | MP0005636_abnormal_mineral_homeostasis | 1.25185401 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.20554848 |
| 30 | MP0010368_abnormal_lymphatic_system | 1.13869417 |
| 31 | MP0004782_abnormal_surfactant_physiolog | 1.08932248 |
| 32 | MP0003866_abnormal_defecation | 1.07890527 |
| 33 | MP0008872_abnormal_physiological_respon | 1.04506509 |
| 34 | MP0005451_abnormal_body_composition | 1.02268055 |
| 35 | MP0005166_decreased_susceptibility_to | 1.01853388 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01040590 |
| 37 | MP0001663_abnormal_digestive_system | 0.95488102 |
| 38 | MP0005408_hypopigmentation | 0.91375488 |
| 39 | MP0004264_abnormal_extraembryonic_tissu | 0.90905949 |
| 40 | MP0002971_abnormal_brown_adipose | 0.90853221 |
| 41 | MP0009764_decreased_sensitivity_to | 0.87880687 |
| 42 | MP0001664_abnormal_digestion | 0.85647281 |
| 43 | MP0003879_abnormal_hair_cell | 0.85201506 |
| 44 | MP0009642_abnormal_blood_homeostasis | 0.84625792 |
| 45 | MP0009785_altered_susceptibility_to | 0.84126991 |
| 46 | MP0000598_abnormal_liver_morphology | 0.83834450 |
| 47 | MP0000604_amyloidosis | 0.83649551 |
| 48 | MP0000566_synostosis | 0.82864040 |
| 49 | MP0001765_abnormal_ion_homeostasis | 0.80815896 |
| 50 | MP0005381_digestive/alimentary_phenotyp | 0.80580454 |
| 51 | MP0008469_abnormal_protein_level | 0.79951095 |
| 52 | MP0000477_abnormal_intestine_morphology | 0.78502951 |
| 53 | MP0002136_abnormal_kidney_physiology | 0.78263368 |
| 54 | MP0009379_abnormal_foot_pigmentation | 0.75843753 |
| 55 | MP0009763_increased_sensitivity_to | 0.75745323 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 0.71821975 |
| 57 | MP0005376_homeostasis/metabolism_phenot | 0.71700624 |
| 58 | MP0002249_abnormal_larynx_morphology | 0.71237591 |
| 59 | MP0000467_abnormal_esophagus_morphology | 0.71005091 |
| 60 | MP0000678_abnormal_parathyroid_gland | 0.69421108 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 0.68986497 |
| 62 | MP0005535_abnormal_body_temperature | 0.68908992 |
| 63 | MP0003183_abnormal_peptide_metabolism | 0.67943158 |
| 64 | MP0009053_abnormal_anal_canal | 0.63656544 |
| 65 | MP0002168_other_aberrant_phenotype | 0.63215752 |
| 66 | MP0005395_other_phenotype | 0.62943004 |
| 67 | MP0002078_abnormal_glucose_homeostasis | 0.62676629 |
| 68 | MP0001756_abnormal_urination | 0.62507951 |
| 69 | MP0005409_darkened_coat_color | 0.60579898 |
| 70 | MP0001661_extended_life_span | 0.58173620 |
| 71 | MP0001873_stomach_inflammation | 0.56079740 |
| 72 | MP0000462_abnormal_digestive_system | 0.55404186 |
| 73 | MP0005023_abnormal_wound_healing | 0.54504638 |
| 74 | MP0000249_abnormal_blood_vessel | 0.53792768 |
| 75 | MP0001845_abnormal_inflammatory_respons | 0.52709424 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 0.52415260 |
| 77 | MP0003186_abnormal_redox_activity | 0.51356676 |
| 78 | MP0003075_altered_response_to | 0.51065805 |
| 79 | MP0005083_abnormal_biliary_tract | 0.49846064 |
| 80 | MP0005334_abnormal_fat_pad | 0.49540227 |
| 81 | MP0008874_decreased_physiological_sensi | 0.49273199 |
| 82 | MP0005448_abnormal_energy_balance | 0.48750884 |
| 83 | MP0005666_abnormal_adipose_tissue | 0.48563464 |
| 84 | MP0004147_increased_porphyrin_level | 0.47239649 |
| 85 | MP0009780_abnormal_chondrocyte_physiolo | 0.44844180 |
| 86 | MP0000490_abnormal_crypts_of | 0.44376256 |
| 87 | MP0002282_abnormal_trachea_morphology | 0.44325531 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.44249819 |
| 89 | MP0003953_abnormal_hormone_level | 0.43183640 |
| 90 | MP0005058_abnormal_lysosome_morphology | 0.42235229 |
| 91 | MP0005266_abnormal_metabolism | 0.40387541 |
| 92 | MP0005165_increased_susceptibility_to | 0.39935783 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 0.39069293 |
| 94 | MP0009115_abnormal_fat_cell | 0.38845536 |
| 95 | MP0005025_abnormal_response_to | 0.37779078 |
| 96 | MP0005464_abnormal_platelet_physiology | 0.37538669 |
| 97 | MP0003303_peritoneal_inflammation | 0.37080369 |
| 98 | MP0005164_abnormal_response_to | 0.36981143 |
| 99 | MP0003705_abnormal_hypodermis_morpholog | 0.36749204 |
| 100 | MP0002796_impaired_skin_barrier | 0.36031006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.81964901 |
| 2 | Complement deficiency (HP:0004431) | 8.72781369 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.34933978 |
| 4 | Abnormality of complement system (HP:0005339) | 7.19885332 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.07185357 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.68586436 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.31154607 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 6.27371397 |
| 9 | Conjugated hyperbilirubinemia (HP:0002908) | 6.27294894 |
| 10 | Glomerulonephritis (HP:0000099) | 5.23437911 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.21063710 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 5.04102296 |
| 13 | Joint hemorrhage (HP:0005261) | 4.75138151 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 4.73840085 |
| 15 | Xanthomatosis (HP:0000991) | 4.43808721 |
| 16 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.14672439 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.03131277 |
| 18 | Fat malabsorption (HP:0002630) | 3.97055015 |
| 19 | Nephritis (HP:0000123) | 3.89567895 |
| 20 | Hypolipoproteinemia (HP:0010981) | 3.70448674 |
| 21 | Hyperactive renin-angiotensin system (HP:0000841) | 3.65651017 |
| 22 | Hemorrhage of the eye (HP:0011885) | 3.35675129 |
| 23 | Hyperammonemia (HP:0001987) | 3.35528743 |
| 24 | Spontaneous abortion (HP:0005268) | 3.30556348 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.29059666 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.26488945 |
| 27 | Alkalosis (HP:0001948) | 3.25097121 |
| 28 | Steatorrhea (HP:0002570) | 2.90654854 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 2.87694602 |
| 30 | Vascular calcification (HP:0004934) | 2.80504516 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 2.76280763 |
| 32 | Hydroxyprolinuria (HP:0003080) | 2.70891780 |
| 33 | Abnormality of proline metabolism (HP:0010907) | 2.70891780 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 2.66206933 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.66206933 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 2.66053746 |
| 37 | Decreased circulating renin level (HP:0003351) | 2.62199756 |
| 38 | Abnormality of vitamin metabolism (HP:0100508) | 2.61645395 |
| 39 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.61398822 |
| 40 | Hyperglycinemia (HP:0002154) | 2.60806007 |
| 41 | Delayed CNS myelination (HP:0002188) | 2.53861527 |
| 42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.49304796 |
| 43 | Cardiovascular calcification (HP:0011915) | 2.47586223 |
| 44 | Abnormality of methionine metabolism (HP:0010901) | 2.47070993 |
| 45 | Epidermoid cyst (HP:0200040) | 2.40375748 |
| 46 | Rickets (HP:0002748) | 2.39067453 |
| 47 | Gingival bleeding (HP:0000225) | 2.37757261 |
| 48 | Malnutrition (HP:0004395) | 2.37598602 |
| 49 | Abnormality of renin-angiotensin system (HP:0000847) | 2.34772136 |
| 50 | Hyperbilirubinemia (HP:0002904) | 2.33993815 |
| 51 | Metabolic acidosis (HP:0001942) | 2.32567316 |
| 52 | Neonatal hypoglycemia (HP:0001998) | 2.28562835 |
| 53 | Flat acetabular roof (HP:0003180) | 2.27436410 |
| 54 | Metabolic alkalosis (HP:0200114) | 2.26818941 |
| 55 | Hyperglycinuria (HP:0003108) | 2.22531769 |
| 56 | Generalized aminoaciduria (HP:0002909) | 2.20447270 |
| 57 | Purpura (HP:0000979) | 2.19607260 |
| 58 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.16730292 |
| 59 | Gout (HP:0001997) | 2.16382122 |
| 60 | Abnormality of serum amino acid levels (HP:0003112) | 2.14447750 |
| 61 | Hypercholesterolemia (HP:0003124) | 2.13723661 |
| 62 | Ileus (HP:0002595) | 2.12888427 |
| 63 | Mitral stenosis (HP:0001718) | 2.12315107 |
| 64 | Osteomalacia (HP:0002749) | 2.11876750 |
| 65 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.11585742 |
| 66 | Rhinitis (HP:0012384) | 2.09341493 |
| 67 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.08496052 |
| 68 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.08496052 |
| 69 | Abdominal distention (HP:0003270) | 2.06858826 |
| 70 | Thrombophlebitis (HP:0004418) | 2.06794496 |
| 71 | Chronic bronchitis (HP:0004469) | 2.04640301 |
| 72 | Abnormality of urine glucose concentration (HP:0011016) | 2.01387113 |
| 73 | Glycosuria (HP:0003076) | 2.01387113 |
| 74 | Abnormal ciliary motility (HP:0012262) | 1.99577438 |
| 75 | Abnormality of purine metabolism (HP:0004352) | 1.97936845 |
| 76 | Cerebral palsy (HP:0100021) | 1.97838781 |
| 77 | Abnormality of chloride homeostasis (HP:0011422) | 1.95422588 |
| 78 | Pulmonary embolism (HP:0002204) | 1.94205337 |
| 79 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.93260834 |
| 80 | Absent/shortened dynein arms (HP:0200106) | 1.93260834 |
| 81 | Hepatocellular carcinoma (HP:0001402) | 1.92058657 |
| 82 | Hyperphosphaturia (HP:0003109) | 1.90847348 |
| 83 | Fair hair (HP:0002286) | 1.89909952 |
| 84 | Pancreatitis (HP:0001733) | 1.85980057 |
| 85 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83816305 |
| 86 | Elevated alkaline phosphatase (HP:0003155) | 1.81317041 |
| 87 | Irritability (HP:0000737) | 1.80109053 |
| 88 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.79674985 |
| 89 | Abnormality of the nasal mucosa (HP:0000433) | 1.77937065 |
| 90 | Ketosis (HP:0001946) | 1.76613384 |
| 91 | Nasal polyposis (HP:0100582) | 1.75137569 |
| 92 | Bronchiectasis (HP:0002110) | 1.69630331 |
| 93 | Skin nodule (HP:0200036) | 1.69509541 |
| 94 | Increased purine levels (HP:0004368) | 1.67486051 |
| 95 | Hyperuricemia (HP:0002149) | 1.67486051 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.67149260 |
| 97 | Hyperaldosteronism (HP:0000859) | 1.66433830 |
| 98 | Nephrolithiasis (HP:0000787) | 1.65333662 |
| 99 | Joint swelling (HP:0001386) | 1.65293051 |
| 100 | Widely patent fontanelles and sutures (HP:0004492) | 1.65174492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 5.01033215 |
| 2 | EPHA2 | 4.71559387 |
| 3 | LMTK2 | 4.69849548 |
| 4 | ERN1 | 4.41898727 |
| 5 | RIPK1 | 3.98625727 |
| 6 | PIK3CA | 3.96619314 |
| 7 | ACVR1B | 3.85183779 |
| 8 | MAPK15 | 2.75270988 |
| 9 | FGFR4 | 2.40306018 |
| 10 | PRKG2 | 1.97180056 |
| 11 | MET | 1.89104803 |
| 12 | MAP3K2 | 1.88467979 |
| 13 | EPHA3 | 1.73860294 |
| 14 | TYK2 | 1.67612421 |
| 15 | TRIB3 | 1.55177494 |
| 16 | MST4 | 1.50257480 |
| 17 | PTK6 | 1.44061079 |
| 18 | EPHB1 | 1.35825440 |
| 19 | PRKAA2 | 1.28843669 |
| 20 | STK39 | 1.28431213 |
| 21 | MAP3K3 | 1.25326121 |
| 22 | EPHB2 | 1.23924309 |
| 23 | MYLK | 1.22618278 |
| 24 | STK24 | 1.21435248 |
| 25 | MAPKAPK3 | 1.18275419 |
| 26 | FGFR3 | 1.16956715 |
| 27 | PRKACG | 1.14673090 |
| 28 | MAP3K12 | 1.12066244 |
| 29 | PDPK1 | 1.10037533 |
| 30 | ERBB2 | 1.09248501 |
| 31 | MAP3K1 | 1.04960404 |
| 32 | PDK2 | 1.03526540 |
| 33 | TBK1 | 1.02577241 |
| 34 | MAPK11 | 1.02340878 |
| 35 | FER | 1.02145004 |
| 36 | OXSR1 | 1.01305555 |
| 37 | SIK1 | 1.00292194 |
| 38 | ABL2 | 1.00045943 |
| 39 | PRPF4B | 0.99852065 |
| 40 | NLK | 0.97986109 |
| 41 | SMG1 | 0.92947513 |
| 42 | MAP2K2 | 0.87790905 |
| 43 | TESK1 | 0.84489830 |
| 44 | EPHA4 | 0.73525655 |
| 45 | ZAP70 | 0.66991340 |
| 46 | PDK1 | 0.65441332 |
| 47 | MAP2K6 | 0.63835852 |
| 48 | IGF1R | 0.62070251 |
| 49 | PIK3CG | 0.61920786 |
| 50 | JAK1 | 0.61775165 |
| 51 | TAOK1 | 0.59076668 |
| 52 | GRK6 | 0.57666446 |
| 53 | PRKCA | 0.57635467 |
| 54 | MAP3K10 | 0.55022999 |
| 55 | DYRK1B | 0.52784293 |
| 56 | SRC | 0.52741964 |
| 57 | CDC42BPA | 0.51559240 |
| 58 | CSK | 0.51231136 |
| 59 | DDR2 | 0.50699033 |
| 60 | PRKCZ | 0.50508906 |
| 61 | MAP2K4 | 0.50014315 |
| 62 | RET | 0.48383240 |
| 63 | GRK1 | 0.47810799 |
| 64 | ICK | 0.47542341 |
| 65 | JAK2 | 0.46506733 |
| 66 | PTK2 | 0.45641837 |
| 67 | CAMK2G | 0.45443085 |
| 68 | MAP3K11 | 0.44979386 |
| 69 | PRKAA1 | 0.43940379 |
| 70 | CAMK2D | 0.43937727 |
| 71 | PRKG1 | 0.43583928 |
| 72 | EEF2K | 0.42042042 |
| 73 | PRKACA | 0.41844609 |
| 74 | STK38 | 0.40604769 |
| 75 | PRKCQ | 0.37965591 |
| 76 | CDK6 | 0.36357221 |
| 77 | IRAK1 | 0.34025694 |
| 78 | NEK6 | 0.33375325 |
| 79 | MATK | 0.32995548 |
| 80 | PKN2 | 0.32915696 |
| 81 | BCKDK | 0.31341731 |
| 82 | MAP3K7 | 0.30660378 |
| 83 | MAPK7 | 0.29222034 |
| 84 | SGK1 | 0.28852185 |
| 85 | NEK1 | 0.28384162 |
| 86 | PRKCI | 0.27179990 |
| 87 | PRKCD | 0.27023292 |
| 88 | KSR2 | 0.26968600 |
| 89 | TRPM7 | 0.26198703 |
| 90 | PRKCB | 0.25863082 |
| 91 | CSNK1A1 | 0.23341105 |
| 92 | IKBKE | 0.22852658 |
| 93 | TIE1 | 0.22812088 |
| 94 | LRRK2 | 0.22683431 |
| 95 | RIPK4 | 0.21874663 |
| 96 | PAK4 | 0.21775364 |
| 97 | FYN | 0.21334642 |
| 98 | CSF1R | 0.20578858 |
| 99 | MAP2K1 | 0.16953694 |
| 100 | MAP4K1 | 0.16863648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.17706049 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.59499082 |
| 3 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.49133668 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.36024310 |
| 5 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.32581046 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.17770678 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.13682717 |
| 8 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.12369126 |
| 9 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.02890189 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.89880031 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.75081291 |
| 12 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.66819336 |
| 13 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.64274510 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.60795339 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.51419758 |
| 16 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.45979212 |
| 17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.35545761 |
| 18 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 2.25492478 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.07537377 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.86417205 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.84168215 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.81975439 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.78725945 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.76121843 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.71952972 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.57759406 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.55629900 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.54154676 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.49863362 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39629970 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25602486 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.24987287 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21325670 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.19154253 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17159780 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.14230751 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.12802997 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.10988116 |
| 39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06283477 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.00650603 |
| 41 | Prion diseases_Homo sapiens_hsa05020 | 0.97095635 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.96291132 |
| 43 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94354921 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92315383 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91586620 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90763198 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.88262303 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84315899 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73526854 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 0.73391003 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70634686 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67267959 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.66243395 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63023510 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61339479 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60395821 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57689191 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56724389 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55428848 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55427291 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54921359 |
| 62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.50425873 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43121041 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40214384 |
| 65 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.39053031 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.34306041 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32874682 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31392249 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.29423390 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22176137 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20946642 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.20163323 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.19669486 |
| 74 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.18693401 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18329283 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.14182027 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.13959606 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.12873420 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12850688 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.11761224 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.07899165 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.07309103 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.04807396 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.02902617 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.02579526 |
| 86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.01982388 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.01017015 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00299334 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1537036 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1330723 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.1298024 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1071510 |
| 93 | Tight junction_Homo sapiens_hsa04530 | -0.1022910 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0993750 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0965924 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.0869559 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0412527 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0362152 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0197988 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0042545 |

